Seeing Is Believing
KZIA is currently covered by 2 analysts with an average price target of $16.24. This is a potential upside of $8.13 (100.25%) from yesterday's end of day stock price of $8.11.
Kazia Therapeutics Ltd ADR's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of KZIA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 107.67 days.
Highest price target for KZIA is $18, Lowest price target is $15, average price target is $16.5.
Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 28-Jan-2026. First documented stock forecast 05-Jan-2021.
Currently out of the existing stock ratings of KZIA, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Apr-2023
$18
$9.75 (118.18%)
$18
1 months 12 days ago
(28-Jan-2026)
1/5 (20%)
$11.44 (174.39%)
146
Buy Since 11-Jun-2025
$15
$6.75 (81.82%)
9 months 1 days ago
(11-Jun-2025)
1/1 (100%)
$5.46 (57.23%)
177
Buy
$18
$17.59 (4290.24%)
4 years 4 months 25 days ago
(15-Oct-2021)
0/1 (0%)
$7.5 (71.43%)
What is KZIA (Kazia Therapeutics Ltd ADR) average time for price targets to be met?
Which analyst has the current highest performing score on KZIA (Kazia Therapeutics Ltd ADR) with a proven track record?
Which analyst has the current lower performing score on KZIA (Kazia Therapeutics Ltd ADR) with a proven track record?
Which analyst has the most public recommendations on KZIA (Kazia Therapeutics Ltd ADR)?
Which analyst is the currently most bullish on KZIA (Kazia Therapeutics Ltd ADR)?
Which analyst is the currently most reserved on KZIA (Kazia Therapeutics Ltd ADR)?